A patent ductus arteriosus (PDA) question looks deceptively simple—until the answer choices start blurring together with VSDs, ASDs, and “continuous murmurs” that aren’t actually PDAs. The fastest way to consistently nail these is to treat every option like it’s trying to teach you a rule. Let’s do a classic Q-bank-style vignette, pick the correct answer, then dissect each distractor the way the exam writers intended.
Clinical Vignette (Q-Bank Style)
A 2-day-old premature infant in the NICU develops tachypnea and difficulty feeding. Pregnancy was complicated by maternal rubella infection in the first trimester. On exam, the infant has bounding pulses and a wide pulse pressure. Cardiac auscultation reveals a continuous, “machine-like” murmur best heard at the left infraclavicular area.
Which of the following is the most appropriate next step in management?
A. Administer indomethacin
B. Administer alprostadil (PGE₁)
C. Close the defect with device closure immediately
D. Give inhaled nitric oxide
E. Administer ibuprofen is contraindicated in premature infants
F. Give high-dose loop diuretics as definitive therapy
The Diagnosis: Patent Ductus Arteriosus (PDA)
Why PDA fits best
Key clues:
- Premature infant (PDA more common in prematurity)
- Maternal rubella (classic association with PDA)
- Continuous machine-like murmur at left upper sternal border/infraclavicular
- Bounding pulses + wide pulse pressure (diastolic runoff from aorta → PA)
Pathophysiology in one line
Failure of ductus arteriosus closure leads to left-to-right shunt (aorta → pulmonary artery) after birth because systemic vascular resistance exceeds pulmonary vascular resistance.
Correct Answer: A. Administer indomethacin
Why indomethacin works
Indomethacin (and ibuprofen) are NSAIDs that inhibit COX → decrease prostaglandins (especially PGE₂). Since prostaglandins keep the ductus open, lowering them promotes closure.
High-yield:
- Functional closure typically within 12–24 hours after birth
- Anatomic closure occurs over weeks
- PDA is kept open by PGE₂ and low oxygen tension
- PDA closes with increased O₂ tension and decreased prostaglandins
Practical Step 2 framing
- Hemodynamically significant PDA (respiratory distress, feeding difficulty, pulmonary overcirculation) → attempt medical closure first (NSAID), unless contraindicated.
Now Let’s Destroy the Distractors (and learn the rules)
B. Administer alprostadil (PGE₁)
This is the “ductus opener,” not the closer.
When you use PGE₁ (alprostadil):
- To maintain ductal patency in ductal-dependent congenital heart disease, e.g.:
- Transposition of the great arteries (TGA) (needs mixing)
- Tricuspid atresia
- Pulmonary atresia
- Tetralogy of Fallot (some severe forms)
- Hypoplastic left heart syndrome
- Critical coarctation of the aorta
High-yield adverse effect: Apnea (boards love this—monitor airway).
Why it’s wrong here: This infant’s problem is too much ductal flow (L→R shunt), not too little systemic/pulmonary blood flow.
C. Close the defect with device closure immediately
Interventional closure is real—but “immediately” is the trap.
When closure procedures are appropriate:
- PDA persists despite NSAIDs
- NSAIDs contraindicated (e.g., severe renal dysfunction, NEC risk context-specific)
- Older infant/child with persistent PDA
- Large PDA causing significant shunt/heart failure
Why it’s wrong here: First-line in a premature neonate with PDA is usually medical closure (indomethacin/ibuprofen) unless contraindicated.
D. Give inhaled nitric oxide
Nitric oxide is a selective pulmonary vasodilator.
When you use inhaled NO:
- Persistent pulmonary hypertension of the newborn (PPHN)
- Severe pulmonary vasoconstriction/hypoxemia with high pulmonary pressures
Why it’s wrong here: PDA is about ductal patency and prostaglandins, not primary pulmonary vasoconstriction. Also, pulmonary vasodilation could theoretically increase pulmonary overcirculation in a significant L→R shunt.
E. Administer ibuprofen is contraindicated in premature infants
This is false and aims at confusing you into thinking only indomethacin is used.
High-yield:
- Indomethacin or ibuprofen can both close PDA by decreasing prostaglandins.
- Many institutions use ibuprofen as an alternative (often similar efficacy with different side effect profiles depending on context).
Real contraindications/concerns for NSAID closure (conceptual USMLE level):
- Significant renal dysfunction (NSAIDs constrict afferent arteriole)
- Risk of necrotizing enterocolitis (NEC) / GI bleeding
- Thrombocytopenia/bleeding risk (varies by scenario)
Why it’s wrong here: Ibuprofen is not categorically contraindicated in prematurity.
F. Give high-dose loop diuretics as definitive therapy
Diuretics can treat symptoms of volume overload/heart failure, but they do not fix the shunt.
Why it’s wrong:
- PDA is a structural shunt lesion; definitive closure requires NSAID (medical) or device/surgery.
- Symptomatic management alone misses the mechanism.
Extra trap: Loop diuretics can increase renal prostaglandins in some contexts—clinically nuanced, but for USMLE the key is: not definitive.
How PDA Presents: Your Mental “Snapshot”
| Feature | PDA |
|---|---|
| Murmur | Continuous “machine-like” |
| Best heard | Left infraclavicular / LUSB |
| Pulses | Bounding |
| Pulse pressure | Wide |
| Shunt direction (initially) | Left → right |
| Key associations | Prematurity, maternal rubella |
| Treatment (close) | Indomethacin/ibuprofen |
| Treatment (keep open) | PGE₁ (alprostadil) |
High-Yield Complications (What the Question Might Be “Secretly” Testing)
1) Eisenmenger syndrome (late complication)
If a large PDA is uncorrected:
- Chronic pulmonary overcirculation → pulmonary vascular remodeling → pulmonary HTN
- Shunt reverses to right-to-left
Board-classic clue: Differential cyanosis
- Cyanosis of lower extremities but not upper extremities
- Why? PDA connects to aorta distal to the left subclavian artery, so desaturated blood preferentially goes to the descending aorta → legs.
2) Endocarditis risk
Persistent PDA can predispose to infective endocarditis (testable but less common than with some other lesions).
Rapid Differentials: Don’t Confuse These Murmurs
PDA vs VSD vs ASD (quick discriminator)
- PDA: continuous machine-like + bounding pulses/wide PP
- VSD: holosystolic at LLSB (often harsh); small VSD can be louder
- ASD: fixed split S2 (increased flow across pulmonic valve), systolic ejection murmur at LUSB
Q-Bank Takeaways (The Rules You’re Supposed to Learn)
- PDA closure: NSAIDs (indomethacin/ibuprofen) ↓ PGE₂
- Keep ductus open: PGE₁ (alprostadil) for ductal-dependent lesions
- PDA hallmark: continuous murmur + bounding pulses + wide pulse pressure
- Rubella + prematurity are classic association anchors
- Know differential cyanosis as the Eisenmenger-PDA giveaway